Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A routine method for the establishment of permanent growing lymphoblastoid cell lines.

Literature DB >> 3017841

A routine method for the establishment of permanent growing lymphoblastoid cell lines.

Abstract

Permanent lymphoblastoid cell lines are of great practical value in human clinical and experimental genetics. A detailed protocol for routine use is given for the establishment of lymphoblastoid lines from peripheral blood using Epstein-Barr virus and the immunosuppressivum Cyclosporin A. In addition, the biologic basis of this transformation system is briefly summarized.

Entities: Species

Mesh：

Substances：

Year: 1986 PMID： 3017841 DOI： 10.1007/bf00279094

Source DB: PubMed Journal: Hum Genet ISSN： 0340-6717 Impact factor: 4.132

51 in total

1. Possibility of EB virus preferentially transforming a subpopulation of human B lymphocytes.

Authors: C M Steel; J Philipson; E Arthur; S E Gardiner; M S Newton; R V McIntosh
Journal: Nature Date: 1977 Dec 22-29 Impact factor: 49.962

2. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes.

Authors: D J Moss; A B Rickinson; J H Pope
Journal: Int J Cancer Date: 1978-12 Impact factor: 7.396

3. Establishment of continuous lymphoblast cultures from leukocytes of gibbons (Hylobates lar).

Authors: J Werner; G Henle; C A Pinto; R F Haff; W Henle
Journal: Int J Cancer Date: 1972-11 Impact factor: 7.396

4. Persistence of Epstein-Barr virus in the parotid gland.

Authors: H Wolf; M Haus; E Wilmes
Journal: J Virol Date: 1984-09 Impact factor: 5.103

5. Epstein-Barr virus and carcinoma.

Authors: H Wolf
Journal: Nature Date: 1984 Dec 20-1985 Jan 2 Impact factor: 49.962

6. Epstein-Barr virus-induced transformation of human leukocytes after cell fractionation.

Authors: U Schneider; H zur Hausen
Journal: Int J Cancer Date: 1975-01-15 Impact factor: 7.396

7. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures.

Authors: D J Moss; A B Rickinson; J H Pope
Journal: Int J Cancer Date: 1979-05-15 Impact factor: 7.396

8. The characterization of high-resolution G-banded chromosomes of man.

Authors: J J Yunis; J R Sawyer; D W Ball
Journal: Chromosoma Date: 1978-08-14 Impact factor: 4.316

9. Spliced RNA from the IR1-U2 region of Epstein-Barr virus: presence of an open reading frame for a repetitive polypeptide.

Authors: M Bodescot; B Chambraud; P Farrell; M Perricaudet
Journal: EMBO J Date: 1984-08 Impact factor: 11.598

10. Characteristics of Epstein-Barr virus activation of human B lymphocytes.

Authors: A G Bird; S Britton; I Ernberg; K Nilsson
Journal: J Exp Med Date: 1981-09-01 Impact factor: 14.307

223 in total

1. Cloning, sequencing, and analysis of inv8 chromosome breakpoints associated with recombinant 8 syndrome.

Authors: S L Graw; T Sample; J Bleskan; E Sujansky; D Patterson
Journal: Am J Hum Genet Date: 2000-03 Impact factor: 11.025

2. Molecular cytogenetic characterization of the EBV-producing cell line B95-8 (Saguinus oedipus, Platyrrhini) by chromosome sorting and painting.

Authors: S Müller; M Neusser; P C O'Brien; J Wienberg
Journal: Chromosome Res Date: 2001 Impact factor: 5.239

3. Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans.

Authors: Andrew J Saykin; Li Shen; Tatiana M Foroud; Steven G Potkin; Shanker Swaminathan; Sungeun Kim; Shannon L Risacher; Kwangsik Nho; Matthew J Huentelman; David W Craig; Paul M Thompson; Jason L Stein; Jason H Moore; Lindsay A Farrer; Robert C Green; Lars Bertram; Clifford R Jack; Michael W Weiner
Journal: Alzheimers Dement Date: 2010-05 Impact factor: 21.566

4. Genetic linkage and heterogeneity in type I Charcot-Marie-Tooth disease (hereditary motor and sensory neuropathy type I).

Authors: P F Chance; T D Bird; P O'Connell; H Lipe; J M Lalouel; M Leppert
Journal: Am J Hum Genet Date: 1990-12 Impact factor: 11.025

5. Physical localisation of the breakpoints of a constitutional translocation t(5;6)(q21;q21) in a child with bilateral Wilms' tumour.

Authors: P R Hoban; R L Cowen; E L Mitchell; D G Evans; M Kelly; P J Howard; J Heighway
Journal: J Med Genet Date: 1997-04 Impact factor: 6.318

6. Delineation of complex chromosomal rearrangements: evidence for increased complexity.

Authors: Caroline Astbury; Laurie A Christ; David J Aughton; Suzanne B Cassidy; Atsuko Fujimoto; Beth A Pletcher; Irwin A Schafer; Stuart Schwartz
Journal: Hum Genet Date: 2004-02-07 Impact factor: 4.132

7. Assignment of a gene (NEMI) for autosomal dominant nemaline myopathy to chromosome I.

Authors: N G Laing; B T Majda; P A Akkari; M G Layton; J C Mulley; H Phillips; E A Haan; S J White; A H Beggs; L M Kunkel
Journal: Am J Hum Genet Date: 1992-03 Impact factor: 11.025

8. Prediction of phenotype for acetylation and for debrisoquine hydroxylation by DNA-tests in healthy human volunteers.

Authors: T Graf; F Broly; F Hoffmann; M Probst; U A Meyer; H Howald
Journal: Eur J Clin Pharmacol Date: 1992 Impact factor: 2.953

9. No evidence for linkage of familial hypertrophic cardiomyopathy and chromosome 14q1 locus D14S26 in a Chinese family: evidence for genetic heterogeneity.

Authors: Y L Ko; W P Lien; J J Chen; C W Wu; T K Tang; C C Liew
Journal: Hum Genet Date: 1992-08 Impact factor: 4.132

10. In vitro sensitization of T cells with DC-associated/delivered HIV constructs can induce a polyfunctional CTL response, memory T-cell response, and virus suppression.

Authors: Swarali Kurle; Madhuri Thakar; Ashwini Shete; Ramesh Paranjape
Journal: Viral Immunol Date: 2012-01-10 Impact factor: 2.257